My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
Invest in the best stock opportunities right now and every time.
Start Systematic Stock Investing …in less than a minute.
BSE: 532981 | NSE: | Pharmaceuticals & Drugs | Small Cap
1. Is Ameya Laboratories Ltd. a good quality company?
Data is not available for this company.
2. Is Ameya Laboratories Ltd. undervalued or overvalued?
No data found
3. Is Ameya Laboratories Ltd. a good buy now?
No data found
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | TTM | |||
| ROCE % ⓘ | 0% | 14.2% | 27.2% | 32.7% | 37.2% | 31.6% | 15.5% | 13.3% | 11% | 7.8% | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 0 | 26.3 | 62.7 | 90.3 | 108 | 150 | 161 | 204 | 273 | 268 | 160 | ||
| YoY Gr. Rt. % | - | NA | 138% | 44.1% | 19.4% | 39.5% | 6.9% | 27.2% | 33.4% | -1.7% | - | ||
| Adj EPS ⓘ | 0 | 0.1 | 0.1 | 0.4 | 0.8 | 1.1 | 0.7 | 0.9 | 0.7 | 0.2 | -0.8 | ||
| YoY Gr. Rt. % | - | NA | 180% | 178.6% | 112.8% | 31.3% | -37.6% | 29.4% | -25% | -75.8% | - | ||
| BVPS (₹) ⓘ | 0 | 0.4 | 0.5 | 0.9 | 2 | 3.1 | 5.8 | 6.4 | 6.5 | 6.7 | 0 | ||
| Adj Net Profit ⓘ | 0 | 0.5 | 2.1 | 5.7 | 13.2 | 18 | 16.3 | 21.2 | 16.1 | 3.8 | -20 | ||
| Cash Flow from Ops. ⓘ | 0 | 3.7 | -0.7 | -4.7 | 4.6 | -6.6 | -42.4 | 13 | 28.5 | -10.1 | - | ||
| Debt/CF from Ops. ⓘ | 0 | 1.8 | -15.4 | -3.7 | 5.7 | -6.1 | -1 | 6.2 | 3.4 | -12.9 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | NA | 20% | 18.6% | -1.7% | ||||||||
| Adj EPS ⓘ | NA | -28.1% | -38.3% | -75.8% | ||||||||
| BVPS ⓘ | 0 | 27.6 | 5.1 | 3.4 | ||||||||
| Share Price | - | - | - | - | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | TTM | ||
| Return on Equity % ⓘ | 0 | 11.8 | 33.6 | 54.6 | 58.8 | 43.2 | 16.5 | 13.8 | 10 | 2.3 | -24.2 | |
| Op. Profit Mgn % ⓘ | 0 | 7.5 | 9.3 | 12.1 | 21 | 22.4 | 20.9 | 17.7 | 16.9 | 14.8 | 6.9 | |
| Net Profit Mgn % ⓘ | 0 | 2.1 | 3.3 | 6.3 | 12.2 | 12 | 10.2 | 10.4 | 5.9 | 1.4 | -12.4 | |
| Debt to Equity ⓘ | 0 | 1.6 | 1.4 | 1.4 | 0.8 | 0.8 | 0.3 | 0.5 | 0.6 | 0.8 | - | |
| Working Cap Days ⓘ | 0 | 0 | 111 | 113 | 126 | 160 | 271 | 296 | 221 | 238 | 0 | |
| Cash Conv. Cycle ⓘ | 0 | 0 | 11 | 24 | 48 | 89 | 169 | 182 | 143 | 169 | 0 | |
No data to display
Return on Equity has declined versus last 3 years average to %
Sales growth has been subdued in last 3 years %
Sales growth is not so good in last 4 quarters at %
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | -0.8 | - |
| TTM Sales (₹ Cr.) | 160 | - |
| BVPS (₹.) ⓘ | 0 | - |
| Reserves (₹ Cr.) ⓘ | -61 | - |
| P/BV ⓘ | 0.00 | - |
| PE ⓘ | 0.00 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 0.23 / 0.25 |
| All Time Low / High (₹) | 0.17 / 28.57 |
| Market Cap (₹ Cr.) | 5.9 |
| Equity (₹ Cr.) | 24.5 |
| Face Value (₹) | 1 |
| Industry PE ⓘ | 37 |
| Pledged * | 52.99 | 37.42 | 45.12 | 45.12 | 65.96 | 66.12 | 69.89 | 69.16 | 74.84 | 73.79 |
Anu's Laboratories is an ISO 9001:2000 certified company established in 1996, engaged in the manufacture of quality drug intermediates to meet the needs of international customers. The optimized process of 2, 4- Dichloro- 5 Fluoro Acetophenone has enabled the brand to establish itself as the flagship product of the organization. It is available to its wide customer base as a competitive product of the highest quality. Other high quality intermediates such as Chlorohexanone, 1, 3-Dibromo Propane are also available to its valued customers. The company is also producing Methyl- 4 (4-Chloro 1 oxo butyl), a Di-Methyl Acetate. Its state-of-the-art R&D facilities, located at Balanagar, Hyderabad, support the process of product development, contract research and customised synthesis programmes of the organization.
The company has entered into a job work agreement with Nitya Laboratories for manufacture of Sodium Methoxide or Sodium Methylate Solution and Powder and CIS (+) Hydroxide Lactum. Nitya Laboratories is one of the promoter group company involved in the manufacturing of fine chemicals and intermediates.
In 2010 Anu's Laboratories acquired Stilbene Chemicals Ltd.
Products
Achievements
